Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity

Published:2009-01 Issue:1 Volume:38 Page:48-55
ISSN:0147-9563
Container-title:Heart & Lung
language:en
Short-container-title:Heart & Lung

Author:

Yamakage Michiaki,Iwasaki Sohshi,Jeong Seong-Wook,Satoh Jun-Ichi,Namiki Akiyoshi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference49 articles.

1. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF);Hjalmarson;JAMA,2000

2. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches;Pharmacotherapy,2000

3. ACC/AHA guidelines for the management of patients with acute myocardial infarction;Ryan;J Am Coll Cardiol,1996

4. Effect of a beta-adrenergic blocking agent, propranolol, on asthmatics;McMeill;Lancet,1964

5. Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane;Raine;Br J Med (Clin Res Ed),1981

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Risks and Benefits of Hypotensive Anesthesia and Piezosurgical Instruments in Bimaxillary Surgery;Cureus;2024-08-21

2. The Impact of beta blockade on the cardio-respiratory system and symptoms during exercise;Current Research in Physiology;2021

3. Changing Paradigms of Bedside Clinical Teaching;Cureus;2020-05-13

4. Radioiodination and biological evaluation of landiolol as a tracer for myocardial perfusion imaging: preclinical evaluation and diagnostic nuclear imaging;Radiochimica Acta;2018-09-01

5. Answering letter to remark of Dr’s Frank and Fitzgerald;European Journal of Clinical Pharmacology;2018-01-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3